Tadakazu Hisamatsu

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: “Safety evaluation of ustekinumab for moderate-to-severe ulcerative colitis”.

Safety evaluation of ustekinumab for moderate-to-severe ulcerative colitis

Expert Opinion on Drug Safety(2022)10.1080/14740338.2021.1980536

N/A

0.443DataRank · unranked

7 citations

Minoru Matsuura, Tadakazu Hisamatsu, Jun Miyoshi

NFIL3 Is a Regulator of IL-12 p40 in Macrophages and Mucosal Immunity

UNC Libraries(2020)10.17615/mmyk-3a22

N/A

0.312DataRank · unranked

7 citations

Tadakazu Hisamatsu, Nobuhiko Kamada, Scott D. Pope, Paul B. Rothman, Katsuyoshi Matsuoka +9 more

Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn’s Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies

Journal of Crohn s and Colitis(2024)10.1093/ecco-jcc/jjae164

N/A

0.303DataRank · unranked

5 citations

Marc Ferrante, Remo Panaccione, Brian G. Feagan, О. Б. Щукина, Vipul Jairath +11 more